company background image
BPC

Birzeit Pharmaceuticals PLSE:BPC Stock Report

Last Price

US$4.00

Market Cap

US$155.1m

7D

0%

1Y

50.7%

Updated

28 Sep, 2022

Data

Company Financials
BPC fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends0/6

BPC Stock Overview

Birzeit Pharmaceuticals Company manufactures and markets generic medicines in the Palestinian Authority.

Birzeit Pharmaceuticals Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Birzeit Pharmaceuticals
Historical stock prices
Current Share PriceUS$4.00
52 Week HighUS$4.10
52 Week LowUS$2.64
Beta-0.053
1 Month Change1.27%
3 Month Change0.76%
1 Year Change50.66%
3 Year Change55.43%
5 Year Change65.95%
Change since IPO213.97%

Recent News & Updates

Shareholder Returns

BPCPS PharmaceuticalsPS Market
7D0%-1.8%-0.4%
1Y50.7%-17.4%7.3%

Return vs Industry: BPC exceeded the PS Pharmaceuticals industry which returned -17.4% over the past year.

Return vs Market: BPC exceeded the PS Market which returned 7.3% over the past year.

Price Volatility

Is BPC's price volatile compared to industry and market?
BPC volatility
BPC Average Weekly Movement2.7%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement2.7%
10% most volatile stocks in PS Market5.6%
10% least volatile stocks in PS Market1.3%

Stable Share Price: BPC is not significantly more volatile than the rest of PS stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: BPC's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1974n/aTalal Kadhim Nasereddinhttps://www.bpc.ps

Birzeit Pharmaceuticals Company manufactures and markets generic medicines in the Palestinian Authority. It offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. The company provides its products in various dosage forms, including ampoules, capsules, tablets and caplets, syrups, suspensions and granules, ophthalmic, semi-solids, powder vials, suppositories, and powders.

Birzeit Pharmaceuticals Company Fundamentals Summary

How do Birzeit Pharmaceuticals's earnings and revenue compare to its market cap?
BPC fundamental statistics
Market CapUS$155.06m
Earnings (TTM)US$11.58m
Revenue (TTM)US$47.58m

13.4x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BPC income statement (TTM)
RevenueUS$47.58m
Cost of RevenueUS$29.16m
Gross ProfitUS$18.42m
Other ExpensesUS$6.84m
EarningsUS$11.58m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin38.71%
Net Profit Margin24.34%
Debt/Equity Ratio1.5%

How did BPC perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

17%

Payout Ratio